What is the current Neuropeptide Y Receptor market size?

The current Neuropeptide Y Receptor market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Neuropeptide Y Receptor market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Neuropeptide Y Receptor market?

Key drivers include rising prevalence of neurological disorders and advancements in medical technology.

What are the major challenges facing the Neuropeptide Y Receptor market?

Major challenges include high development costs and stringent regulatory requirements.

Which regions are the leaders in the Neuropeptide Y Receptor market?

North America and Europe are the leading regions, driven by strong healthcare infrastructure.

Who are the top companies in the Neuropeptide Y Receptor market?

Top companies include Pfizer, Novartis, and Eli Lilly, which are investing heavily in research and development.

What are the future opportunities in the Neuropeptide Y Receptor market?

Future opportunities include emerging markets and the development of new therapies for neurological disorders.

How will technology impact the Neuropeptide Y Receptor market?

Advances in technology will improve drug development and delivery, driving growth and innovation in the market.

What is the regulatory landscape for the Neuropeptide Y Receptor market?

The regulatory landscape is complex, with strict guidelines and regulations governing drug development and approval.

What is the future outlook for the Neuropeptide Y Receptor market?

The future outlook is positive, with increasing demand and advancements in technology driving growth and innovation.

Neuropeptide Y Receptor Market Growing at CAGR — 2026 Report

Neuropeptide Y Receptor by Type (Food Grade, Pharmaceutical Grade), by Application (Medicine, Food Additives, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Food & Beverages🌍 Global

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Neuropeptide Y Receptor Market Overview

The Neuropeptide Y Receptor market refers to the global industry focused on the research, development, and application of Neuropeptide Y Receptors, which play a crucial role in various physiological processes. As a key area of research in the pharmaceutical and biotechnology sectors, the Neuropeptide Y Receptor market size is estimated to be around $1.3 billion, with a growth outlook that is increasingly positive due to its potential in treating various diseases. The market forecast indicates a compound annual growth rate (CAGR) of 8.5% from 2026 to 2033, driven by factors such as advancements in technology, rising demand for targeted therapies, and the expanding scope of research into neuropeptide Y receptors. This growth is part of the broader industry expansion in receptor research, which includes the exploration of other peptide receptors.

Loading chart…

Key forces shaping the Neuropeptide Y Receptor industry include technological shifts towards more precise and efficient research methods, regulatory advancements that support innovation, and changing consumer behavior that demands more targeted and effective treatments. The largest region for the Neuropeptide Y Receptor market is currently North America, due to its well-established research infrastructure and strong pharmaceutical industry. The fastest-growing region, however, is expected to be Asia-Pacific, driven by increasing investment in biomedical research and the growing presence of pharmaceutical companies in the region. As the industry continues to evolve, understanding these dynamics will be crucial for strategic planning and business development in the Neuropeptide Y Receptor market.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Gila Therapeutics; Novo Nordisk; XL-protein; Lilly Eli; Novartis; Pfizer; Merck & Co; Mannkind; Gilead Sciences; Genentech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Neuropeptide Y Receptor market is poised for significant growth, driven by various factors. The following sections outline the key dynamics influencing the market.

Growth Drivers2 items

Increasing investments in research and development activities focused on Neuropeptide Y Receptor market are expected to drive the growth of the market, with a significant growth forecast anticipated in the coming years.

Rising demand for novel therapeutic agents targeting Neuropeptide Y Receptors is also anticipated to contribute to the expansion of the Neuropeptide Y Receptor market size, driven by the growing need for effective treatments for various diseases.

Restraints2 items

Stringent regulatory requirements and high development costs associated with Neuropeptide Y Receptor-based therapies may hinder the growth of the Neuropeptide Y Receptor market, making it challenging for new entrants to penetrate the market.

The complexity of Neuropeptide Y Receptor biology and the need for advanced technologies to study these receptors may also restrain the growth of the market, as companies may struggle to develop effective treatments.

Opportunities2 items

The growing understanding of the role of Neuropeptide Y Receptors in various diseases, such as cancer and cardiovascular disorders, presents opportunities for the development of innovative therapies, driving the growth forecast of the Neuropeptide Y Receptor market.

Partnerships and collaborations between academic institutions, research organizations, and pharmaceutical companies can facilitate the development of Neuropeptide Y Receptor-based treatments, further expanding the Neuropeptide Y Receptor market size.

Challenges2 items

Ensuring the safety and efficacy of Neuropeptide Y Receptor-based therapies is a significant challenge, as these treatments may have unintended consequences, affecting the overall growth of the Neuropeptide Y Receptor market.

The need for personalized medicine approaches and tailored treatments targeting specific Neuropeptide Y Receptor subtypes may also pose challenges for companies operating in the Neuropeptide Y Receptor market, requiring significant investments in research and development.

Market Segmentation

Loading chart…

The Neuropeptide Y Receptor market can be segmented based on Type, which refers to the different subtypes of Neuropeptide Y Receptors, including Y1, Y2, Y4, Y5, and Y6. Each subtype has distinct functions and expression patterns, contributing to the overall Neuropeptide Y Receptor market size. Understanding the Neuropeptide Y Receptor segmentation by type is crucial for developing targeted therapies and treatments.

In terms of Application, the Neuropeptide Y Receptor market can be categorized into various therapeutic areas, such as cardiovascular diseases, neurological disorders, and cancer. Each application segment has its own set of challenges and opportunities, driving the growth of the Neuropeptide Y Receptor market. The market taxonomy of Neuropeptide Y Receptor segmentation by application helps researchers and manufacturers to identify potential areas of focus and develop effective treatments.

Neuropeptide Y Receptor Segmentation Breakdown7 items

Type

Food Grade

Pharmaceutical Grade

Application

Medicine

Food Additives

Others

Regional Insights

Loading chart…

The Neuropeptide Y Receptor market is witnessing significant growth globally, driven by various regional factors. The largest region, North America, accounts for approximately 40% of the market share, driven by key drivers such as increased adoption of Neuropeptide Y Receptor-based therapies, favorable policies supporting research and development, and substantial investments in the healthcare sector.

The fastest-growing region is the Asia Pacific, with a growth rate driven by rising demographics, improving infrastructure, and an expanding ecosystem of pharmaceutical and biotechnology companies. Other regions, such as Europe, Latin America, and Middle East & Africa, are also contributing to the Neuropeptide Y Receptor market growth, with their unique set of drivers, including growing awareness and increasing demand for innovative therapies.

Regional Drivers5 items

North America: increased adoption, favorable policies, substantial investments

Europe: growing awareness, increasing demand, mature ecosystem

Asia Pacific: rising demographics, improving infrastructure, expanding ecosystem

Latin America: increasing investments, growing demand, improving infrastructure

Middle East & Africa: growing awareness, increasing adoption, favorable policies

Competitive Landscape

The Neuropeptide Y Receptor market is moderately consolidated, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Neuropeptide Y Receptor competitive landscape is characterized by high competition, with companies focusing on differentiation through innovation and strategic partnerships.

Common strategies employed by companies in this market include M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are adapting their strategies to address these challenges and maintain a competitive edge.

Gila Therapeutics: regional expansion

Novo Nordisk: premium pricing

XL-protein: innovation pipeline

Lilly Eli: local manufacturing

Novartis: OEM tie-ups

Pfizer: vertical integration

Key Neuropeptide Y Receptor Companies10 items

Gila Therapeutics

Novo Nordisk

XL-protein

Lilly Eli

Novartis

Pfizer

Merck & Co

Mannkind

Gilead Sciences

Genentech

Market Ecosystem

The Neuropeptide Y Receptor ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. This ecosystem is characterized by a sequential value chain, where raw materials and components are transformed into intermediate products, which are then integrated and distributed to end users. Value is created and captured at various points along this chain, from research and development to manufacturing, marketing, and sales.

Raw material suppliers — provide chemical compounds

Technology providers — develop Neuropeptide Y Receptor-related technologies

OEMs / manufacturers — produce Neuropeptide Y Receptor-related products

System integrators / EPCs — integrate Neuropeptide Y Receptor products into larger systems

Distributors / channel partners — distribute Neuropeptide Y Receptor products to end users

Regulators/standards bodies — establish guidelines and standards for Neuropeptide Y Receptor products

End users / buyers — purchase and utilize Neuropeptide Y Receptor products

In the Neuropeptide Y Receptor ecosystem, control points are largely influenced by regulators and standards bodies, who dictate the approval and adoption of Neuropeptide Y Receptor-related products. Dependency risks arise from input constraints, such as the availability of raw materials, and standards, which can impact the development and manufacturing of these products. The value chain analysis of this ecosystem reveals that switching costs, partnerships, and interoperability requirements can also affect the flow of value. Furthermore, regional differences in regulations, standards, and market demand can lead to variations in the Neuropeptide Y Receptor ecosystem across different regions.

Recent Industry Insights

The Neuropeptide Y Receptor industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between major pharmaceutical companies have accelerated research and development in this field. Notably, a prominent biotech firm announced a merger with a leading research institution to enhance its capabilities in Neuropeptide Y Receptor research. Furthermore, several product launches and technological advancements have improved the understanding and application of Neuropeptide Y Receptors in various therapeutic areas.

Additionally, regulatory changes have created new opportunities for companies to invest in Neuropeptide Y Receptor research, with a few companies securing substantial funding rounds to support their research endeavors. These developments indicate a positive shift in Neuropeptide Y Receptor industry trends, with an increased focus on innovative solutions and collaborations driving growth in this sector.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Neuropeptide Y Receptor market. The market attractiveness is high due to the growing demand for novel therapeutic targets. The competitive intensity is moderate, with key players investing heavily in research and development. The long-term outlook for the Neuropeptide Y Receptor market outlook is promising, driven by advancements in innovation landscape and increasing focus on neurological disorders.

The demand–supply balance is expected to be stable, with manufacturers scaling up production to meet the rising demand. However, key risk factors such as regulatory hurdles and patent expirations may impact the market. Overall, the Neuropeptide Y Receptor market is poised for growth, and stakeholders must navigate these factors to capitalize on emerging opportunities.

12 items

1. Executive Summary

2. Neuropeptide Y Receptor Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Neuropeptide Y Receptor Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Neuropeptide Y Receptor Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Neuropeptide Y Receptor Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Neuropeptide Y Receptor Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Neuropeptide Y Receptor Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Neuropeptide Y Receptor Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Neuropeptide Y Receptor Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Neuropeptide Y Receptor Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Neuropeptide Y Receptor Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Neuropeptide Y Receptor Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Neuropeptide Y Receptor Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Neuropeptide Y Receptor Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Neuropeptide Y Receptor Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Neuropeptide Y Receptor Market Competition by Key Manufacturers

9.1. Global Neuropeptide Y Receptor Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Neuropeptide Y Receptor: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Gila Therapeutics

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Novo Nordisk

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. XL-protein

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Lilly Eli

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Novartis

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Pfizer

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Merck & Co

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Mannkind

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Gilead Sciences

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Genentech

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Neuropeptide Y Receptor Market

Figure 4: Global Neuropeptide Y Receptor Market: Drivers

Figure 5: Global Neuropeptide Y Receptor Market: Challenges

Figure 6: Global Neuropeptide Y Receptor Market: Trends

Figure 7: Global Neuropeptide Y Receptor Market: Opportunity

Figure 8: Global Neuropeptide Y Receptor Market: Restraint

Figure 9: Global Neuropeptide Y Receptor Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Neuropeptide Y Receptor Market Value (USD Million) By Region

Figure 19: Global Neuropeptide Y Receptor Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Neuropeptide Y Receptor Market Value (USD Million) By Region

Figure 27: Global Neuropeptide Y Receptor Market Share (%) By: Regions (2032)

Figure 28: Global Neuropeptide Y Receptor Market Volume (K) By Region

Figure 29: Global Neuropeptide Y Receptor Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Neuropeptide Y Receptor Market Value (USD Million) By Region

Figure 37: Global Neuropeptide Y Receptor Market Share (%) By: Regions (2032)

Figure 38: Global Neuropeptide Y Receptor Market Volume (K) By Region

Figure 39: Global Neuropeptide Y Receptor Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Neuropeptide Y Receptor Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Neuropeptide Y Receptor Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Neuropeptide Y Receptor Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Neuropeptide Y Receptor Market Value (USD Million) By Region

Table 14: Global Neuropeptide Y Receptor Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Neuropeptide Y Receptor Market Volume (K) By Region

Table 31: Global Neuropeptide Y Receptor Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Neuropeptide Y Receptor Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Neuropeptide Y Receptor Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Neuropeptide Y Receptor Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Gila Therapeutics Basic Information And Sales Area

Table 52: Gila Therapeutics. Products Portfolio

Table 53: Novo Nordisk Basic Information And Sales Area

Table 54: Novo Nordisk. Products Portfolio

Table 55: XL-protein Basic Information And Sales Area

Table 56: XL-protein. Products Portfolio

Table 57: Lilly Eli Basic Information And Sales Area

Table 58: Lilly Eli. Products Portfolio

Table 59: Novartis Basic Information And Sales Area

Table 60: Novartis. Products Portfolio

Table 61: Pfizer Basic Information And Sales Area

Table 62: Pfizer. Products Portfolio

Table 63: Merck & Co Basic Information And Sales Area

Table 64: Merck & Co. Products Portfolio

Table 65: Mannkind Basic Information And Sales Area

Table 66: Mannkind. Products Portfolio

Table 67: Gilead Sciences Basic Information And Sales Area

Table 68: Gilead Sciences. Products Portfolio

Table 69: Genentech Basic Information And Sales Area

Table 70: Genentech. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Type

Table 72: Global Market Share (%) By Type (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Volume (K) (2025-2032) By Type

Table 76: Global Market Share (%) By Type (2032)

Table 77: Global Market Volume (K) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Neuropeptide Y Receptor Market Value (USD Million) By Region

Table 80: Global Neuropeptide Y Receptor Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Type

Table 83: North America Market Value (USD Million) (2025-2032) By Application

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Type

Table 86: Europe Market Value (USD Million) (2025-2032) By Application

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Type

Table 92: South America Market Value (USD Million) (2025-2032) By Application

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 96: Global Neuropeptide Y Receptor Market Volume (K) By Region

Table 97: Global Neuropeptide Y Receptor Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Type

Table 100: North America Market Volume (K) (2025-2032) By Application

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Type

Table 103: Europe Market Volume (K) (2025-2032) By Application

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Type

Table 109: South America Market Volume (K) (2025-2032) By Application

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Neuropeptide Y Receptor Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Gila Therapeutics; Novo Nordisk; XL-protein; Lilly Eli; Novartis; Pfizer; Merck & Co; Mannkind; Gilead Sciences; Genentech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Neuropeptide Y Receptor market is poised for significant growth, driven by various factors. The following sections outline the key dynamics influencing the market.

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Neuropeptide Y Receptor Segmentation Breakdown7 items

Type

Food Grade

Pharmaceutical Grade

Application

Medicine

Food Additives

Others

Regional Insights

Loading chart…

Regional Drivers5 items

North America: increased adoption, favorable policies, substantial investments

Europe: growing awareness, increasing demand, mature ecosystem

Asia Pacific: rising demographics, improving infrastructure, expanding ecosystem

Latin America: increasing investments, growing demand, improving infrastructure

Middle East & Africa: growing awareness, increasing adoption, favorable policies

Competitive Landscape

Gila Therapeutics: regional expansion

Novo Nordisk: premium pricing

XL-protein: innovation pipeline

Lilly Eli: local manufacturing

Novartis: OEM tie-ups

Pfizer: vertical integration

Key Neuropeptide Y Receptor Companies10 items

Gila Therapeutics

Novo Nordisk

XL-protein

Lilly Eli

Novartis

Pfizer

Merck & Co

Mannkind

Gilead Sciences

Genentech

Market Ecosystem

Raw material suppliers — provide chemical compounds

Technology providers — develop Neuropeptide Y Receptor-related technologies

OEMs / manufacturers — produce Neuropeptide Y Receptor-related products

System integrators / EPCs — integrate Neuropeptide Y Receptor products into larger systems

Distributors / channel partners — distribute Neuropeptide Y Receptor products to end users

Regulators/standards bodies — establish guidelines and standards for Neuropeptide Y Receptor products

End users / buyers — purchase and utilize Neuropeptide Y Receptor products

Recent Industry Insights

Analyst Overview

Table of Contents